Optimizaing the Parameters of Soft Tissue Sarcoma Tumors in Irreversible Electroporation Treatment Method

Document Type : Original Article (s)

Authors

1 PhD Student, Department of Medical Physics, School of Medicine, Tarbiat Modares University, Tehran, Iran

2 Professor, Department of Medical Physics, School of Medicine, Tarbiat Modares University, Tehran, Iran

3 Assistant Professor, Department of Radiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

4 Assistant Professor, Department of Surgery, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Abstract

Background: Electroporation is an effective strategy for drug delivery to the target volume, for example in chemotherapy. The efficiency of this method depends on the selection of optimal parameters affecting it. This studay aimed to evaluate the optimum parameters for treatment of soft tissue sarcoma tumors on irreversible electroporation treatments.Methods: The geometry of the tumor was defined using the Mimics software regarding to the gatherd magnetic resonance images (MRI). Using CAD-fix software, the Mimics product geometry was converted to the geometry that could be used in the finite element. The FEMLAB4.4 software utilized to solve equations (Laplace and the biothermal equations). In order to optimize the geometry of the electrodes used in irreversible electroporation, a Genetic Algorithm program was used. The Genetic Algorithm code was written using the MATLAB7.10.0 software.Findings: The induced electric field intensity to the tumor increased with increasing voltage applied to the electrodes and the maximum electric field intensity was observed in the potential of 4000 volts. The average electric field intensity distribution in the tissue was altered by changing the electrode penetration depth, the distance between the electrodes and the thickness of the electrodes. Despite the high electric field utilized to the tumor area, there was only a slight increase in the average temperature of the tumor (37°C). Although the tissue temperature near the end of the electrode could be increased up to 600°C.Conclusion: The optimum effective parameters of irreversible electroporation treatments for tumor ablation could be calculated using the numerical modeling methods.

Keywords

References

  1. Prendergast B, Fiveash JB, Gibbs P, Scarborough MT, Indelicato DJ. Radiotherapy for soft tissue sarcoma of the proximal lower extremity. Sarcoma 2010; 2010: 1-10.
  2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; 59(4): 225-49.
  3. Ferguson WS, Harris MB, Goorin AM, Gebhardt MC, Link MP, Shochat SJ, et al. Presurgical window of carboplatin and surgery and multidrug chemotherapy for the treatment of newly diagnosed metastatic or unresectable osteosarcoma: Pediatric Oncology Group Trial. J Pediatr Hematol Oncol 2001; 23(6): 340-8.
  4. Songur N, Dinc M, Ozdilekcan C, Eke S, Ok U, Oz M. Analysis of lung metastases in patients with primary extremity sarcoma. Sarcoma 2003; 7(2): 63-7.
  5. Neal RE, Garcia PA, Robertson JL, Davalos RV. Experimental characterization of intrapulse tissue conductivity changes for electroporation. Conf Proc IEEE Eng Med Biol Soc 2011; 2011: 5581-4.
  6. Sel D, Mazeres S, Teissie J, Miklavcic D. Finite-element modeling of needle electrodes in tissue from the perspective of frequent model computation. IEEE Trans Biomed Eng 2003; 50(11): 1221-32.
  7. Neal RE, Garcia PA, Robertson JL, Davalos RV. Experimental characterization and numerical modeling of tissue electrical conductivity during pulsed electric fields for irreversible electroporation treatment planning. IEEE Trans Biomed Eng 2012; 59(4): 1076-85.
  8. Miklavcic D, Beravs K, Semrov D, Cemazar M, Demsar F, Sersa G. The importance of electric field distribution for effective in vivo electroporation of tissues. Biophys J 1998; 74(5): 2152-8.
  9. Sekino M, Ueno S. Magnetic resonance imaging of electric properties of living bodies.Biocybernetics and Biomedical Engeneering 2007; 27 (1/2): 177-84.
  10. Corovic S, Zupanic A, Kranjc S, Al SB, Leroy-Willig A, Mir LM, et al. The influence of skeletal muscle anisotropy on electroporation: in vivo study and numerical modeling. Med Biol Eng Comput 2010; 48(7): 637-48.
  11. Miller L, Leor J, Rubinsky B. Cancer cells ablation with irreversible electroporation. Technol Cancer Res Treat 2005; 4(6): 699-705.
  12. Nickfarjam A, Firoozabadi SMP, Kalaghchi B. A multi objective genetic algorithm (MOGA) for optimizing thermal and electrical distribution in tumor ablation by irreversible electroporation. J Biomed Phys Eng 2013; 3(1): 13-24.
  13. Corovic S, Zupanic A, Miklavcic D. Numerical modeling and optimization of electricfield distribution in subcutaneous tumor treatedwith electrochemotherapy using needle electrodes. IEEE Transactions on Plasma Science 2008; 36(4): 1665-72.
  14. Edd JF, Horowitz L, Davalos RV, Mir LM, Rubinsky B. In vivo results of a new focal tissue ablation technique: irreversible electroporation. IEEE Trans Biomed Eng 2006; 53(7): 1409-15.
  15. Trontelj K, Rebersek M, Kanduser M, Serbec VC, Sprohar M, Miklavcic D. Optimization of bulk cell electrofusion in vitro for production of human-mouse heterohybridoma cells. Bioelectrochemistry 2008; 74(1): 124-9.
  16. Frankenhaeuser B, Widen L. Anode break excitation in desheathed frog nerve. J Physiol 1956; 131(1): 243-7.
  17. Stampfli R, Willi M. Membrane potential of a Ranvier node measured after electrical destruction of its membrane. Experientia 1957; 13(7): 297-8.
  18. Davalos RV, Mir IL, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng 2005; 33(2): 223-31.
  19. Maor E, Ivorra A, Leor J, Rubinsky B. The effect of irreversible electroporation on blood vessels. Technol Cancer Res Treat 2007; 6(4): 307-12.
  20. Rubinsky B. Irreversible electroporation in medicine. Technol Cancer Res Treat 2007; 6(4): 255-60.
  21. Rubinsky B, Onik G, Mikus P. Irreversible electroporation: a new ablation modality--clinical implications. Technol Cancer Res Treat 2007; 6(1): 37-48.
  22. Al-Sakere B, Bernat C, Andre F, Connault E, Opolon P, Davalos RV, et al. A study of the immunological response to tumor ablation with irreversible electroporation. Technol Cancer Res Treat 2007; 6(4): 301-6.
  23. Adeyanju OO, Al-Angari HM, Sahakian AV. The optimization of needle electrode number and placement for irreversible electroporation of hepatocellular carcinoma. Radiol Oncol 2012; 46(2): 126-35.
  24. Pavliha D, Kos B, Zupanic A, Marcan M, Sersa G, Miklavcic D. Patient-specific treatment planning of electrochemotherapy: procedure design and possible pitfalls. Bioelectrochemistry 2012; 87: 265-73.
Journal of Isfahan Medical School
Volume 33, Issue 339 - Serial Number 339
May and June 2015
Pages 955-969

Files

History

  • Receive Date: 04 February 2015
  • Revise Date: 06 May 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics